Literature DB >> 28164091

Laboratory monitoring of direct oral anticoagulants (DOACs)-The perfect storm?

Giuseppe Lippi1, Emmanuel J Favaloro2.   

Abstract

Entities:  

Year:  2017        PMID： 28164091      PMCID： PMC5253288          DOI： 10.21037/atm.2017.01.03

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  10 in total

Review 1.  Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors.

Authors:  Emmanuel J Favaloro; Giuseppe Lippi
Journal:  Semin Thromb Hemost       Date:  2015-02-19       Impact factor: 4.180

2.  Laboratory testing for the new oral anticoagulants: a review of current practice.

Authors:  Emmanuel J Favaloro; Roslyn Bonar; Jennifer Butler; Katherine Marsden
Journal:  Pathology       Date:  2013-06       Impact factor: 5.306

3.  Urgent monitoring of direct oral anticoagulants in patients with atrial fibrillation: a tentative approach based on routine laboratory tests.

Authors:  Giuseppe Lippi; Diego Ardissino; Roberto Quintavalla; Gianfranco Cervellin
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 4.  Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus?

Authors:  Giuseppe Lippi; Emmanuel J Favaloro
Journal:  Clin Chem Lab Med       Date:  2015-02       Impact factor: 3.694

5.  Andexanet: Effectively Reversing Anticoagulation.

Authors:  Giuseppe Lippi; Fabian Sanchis-Gomar; Emmanuel J Favaloro
Journal:  Trends Pharmacol Sci       Date:  2016-04-02       Impact factor: 14.819

6.  The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.

Authors:  Roslyn Bonar; Emmanuel J Favaloro; Soma Mohammed; Monica Ahuja; Leonardo Pasalic; John Sioufi; Katherine Marsden
Journal:  Pathology       Date:  2015-12-17       Impact factor: 5.306

7.  Promising gene therapies pose million-dollar conundrum.

Authors:  Erika Check Hayden
Journal:  Nature       Date:  2016-06-16       Impact factor: 49.962

8.  Laboratory economics. Risk or opportunity?

Authors:  Giuseppe Lippi; Mario Plebani
Journal:  Clin Chem Lab Med       Date:  2016-11-01       Impact factor: 3.694

Review 9.  The evolution of anticoagulant therapy.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Carlo Bonfanti; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2015-12-16       Impact factor: 3.443

Review 10.  The new oral anticoagulants and the future of haemostasis laboratory testing.

Authors:  Emmanuel J Favaloro; Giuseppe Lippi
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313
  10 in total
  6 in total

1.  Emerging treatments for hemophilia: patients and their treaters spoilt for choice, but laboratories face a difficult path?

Authors:  Emmanuel J Favaloro; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2017-03

2.  Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends.

Authors:  Giuseppe Lippi; Camilla Mattiuzzi; Gianfranco Cervellin; Emmanuel J Favaloro
Journal:  Ann Transl Med       Date:  2017-08

Review 3.  Plasma contact factors as therapeutic targets.

Authors:  Benjamin F Tillman; Andras Gruber; Owen J T McCarty; David Gailani
Journal:  Blood Rev       Date:  2018-04-12       Impact factor: 8.250

4.  A New Test for the Detection of Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in the Emergency Room Setting.

Authors:  Galit H Frydman; Felix Ellett; Elizabeth M Van Cott; Douglas Hayden; Maulik Majmudar; Charles R Vanderburg; Haley Dalzell; Divya L Padmanabhan; Nick Davis; Julianne Jorgensen; Mehmet Toner; James G Fox; Ronald G Tompkins
Journal:  Crit Care Explor       Date:  2019-08-20

5.  Assessment of Anti-Xa activity in patients receiving concomitant apixaban with strong p-glycoprotein inhibitors and statins.

Authors:  Erin Milner; Michael Ainsworth; Melinda Gleaton; David Bookstaver
Journal:  J Clin Pharm Ther       Date:  2022-01-15       Impact factor: 2.145

6.  Dosing challenges with direct oral anticoagulants in the elderly: a retrospective analysis.

Authors:  Joseph P Fava; Katelyn M Starr; David Ratz; Jennifer L Clemente
Journal:  Ther Adv Drug Saf       Date:  2018-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.